By F. D. Moore, MD; S. I. Woodrow, MD; M. A. Aliapoulios, MD; and R. E. Wilson, MD. Price, $7.50. Pp 105, with 15 tables. Little, Brown & Co., 34 Beacon St, Boston 02108, 1968.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
In the closing years of the 19th century, William Halstead opened the door to modern-day therapy of carcinoma of the breast. His description of the radical mastectomy was rapidly accepted by the medical profession and vigorously applied to this dread disease. Shortly thereafter radiation therapy was introduced for the treatment of this malignancy. Over the succeeding years, changes in operative procedure and radiotherapeutic approach, ablative and additive hormonal therapy, and more recently chemotherapy have been added to the physicians' armamentarium. Unfortunately the rightful place of each of these modalities alone or in combination has not been defined adequately. Confusion as to the most effective application of these procedures still exists in the minds of many clinicians.
Moore and his associates seek to end this confusion by outlining their program for the treatment of this disease. Experience at the Peter Bent Brigham Hospital from 1954 to 1963 forms the basis of
Meyer R. Carcinoma of the Breast. Arch Intern Med. 1969;123(4):475–476. doi:10.1001/archinte.1969.00300140121036
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: